In groundbreaking trials, surgeons to use infected kidneys for transplants
Transplant surgeons at two U.S. hospitals are about to do something long considered taboo: put kidneys from donors with hepatitis C into recipients without the infection. In first-in-the-world clinical trials scheduled to launch later this spring, independent teams from the University of Pennsylvania and Johns Hopkins University will take kidneys from deceased carriers of the hep C virus, put them into patients with renal failure, and then give them a 12-week course of an antiviral therapy in the hopes that they will emerge infection-free.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063